# Zimmer Biomet Holdings, Inc.  Share Price Target ‘$132.72’, now 24.0% Upside Potential

- Link: https://www.directorstalkinterviews.com/zimmer-biomet-holdings-inc.share-price-target-132.72-now-24.0-upside-potential/4121167473
- Published: 2024-08-07T14:57:15+01:00
- Author: Charlotte Edwards

**Zimmer Biomet Holdings, Inc.** with ticker code (ZBH) have now 25 market analysts
covering the stock. The analyst consensus now points to a rating of ‘hold’. The 
target price High/Low ranges between $160.00 and $112.00 suggesting an average analyst
share price target price of $132.72. (at the time of writing). Given that the stocks
previous close was at $107.04 and the analysts are correct then there would likely
be a percentage uptick in value of 24.0%. Also worth taking note is the 50 day moving
average now sits at $109.81 and the 200 moving average now moves to $117.53. The
market capitalization for the company is 22.54B. The current stock price is currently
$109.57 USD

The potential market cap would be $27,949,583,599 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 23.77, revenue per share of $35.89
and a 4.44% return on assets.

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments
include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and 
markets orthopedic reconstructive products; sports medicine, biologics, extremities
and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical 
products; and a suite of integrated digital and robotic technologies that leverage
data, data analytics and artificial intelligence. Its other product category primarily
includes its robotic, surgical and bone cement products. Its products and solutions
help treat patients suffering from disorders of, or injuries to, bones, joints or
supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants,
Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip 
System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular 
System. Its S.E.T. product category includes sports medicine, biologics, foot and
others.

Share on:
